CY1110218T1 - Treatment of Aspergillus infections with thymic alpha 1 - Google Patents

Treatment of Aspergillus infections with thymic alpha 1

Info

Publication number
CY1110218T1
CY1110218T1 CY20101100691T CY101100691T CY1110218T1 CY 1110218 T1 CY1110218 T1 CY 1110218T1 CY 20101100691 T CY20101100691 T CY 20101100691T CY 101100691 T CY101100691 T CY 101100691T CY 1110218 T1 CY1110218 T1 CY 1110218T1
Authority
CY
Cyprus
Prior art keywords
treatment
thymic
alpha
aspergillus
aspergillus infections
Prior art date
Application number
CY20101100691T
Other languages
Greek (el)
Inventor
Guido Rasi
Enrico Garaci
Original Assignee
Sciclone Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04749495A external-priority patent/EP1613340B1/en
Application filed by Sciclone Pharmaceuticals, Inc. filed Critical Sciclone Pharmaceuticals, Inc.
Publication of CY1110218T1 publication Critical patent/CY1110218T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones

Abstract

Μία μέθοδος για την αγωγή ενός ανθρώπου μολυσμένου σε Ασπέργιλλο μέσω χρήσης θυμοσίνης άλφα 1 ως ένας ανοσο-διεγέρτης στην ενεργοποίηση δενδριτικών κυττάρων. Η μέθοδος είναι ειδικότερα χρήσιμη στην πρόληψη μιας λοίμωξης από ασπέργιλλο σε έναν ανοσο-κατασταλμένο ξενιστή που υποβάλλεται σε αγωγή με μεταμόσχευση μυελού των οστών.A method for the treatment of a human infected with Aspergillus by the use of thymosin alfa 1 as an immunostimulant in dendritic cell activation. The method is particularly useful in preventing an aspergillosis infection in an immunosuppressed host undergoing bone marrow transplantation.

CY20101100691T 2003-03-28 2010-07-22 Treatment of Aspergillus infections with thymic alpha 1 CY1110218T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45791103P 2003-03-28 2003-03-28
EP04749495A EP1613340B1 (en) 2003-03-28 2004-03-29 Treatment of aspergillus infections with thymosin alpha 1

Publications (1)

Publication Number Publication Date
CY1110218T1 true CY1110218T1 (en) 2015-01-14

Family

ID=33131730

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100691T CY1110218T1 (en) 2003-03-28 2010-07-22 Treatment of Aspergillus infections with thymic alpha 1

Country Status (5)

Country Link
CN (1) CN100342907C (en)
CY (1) CY1110218T1 (en)
DE (1) DE602004027127D1 (en)
ES (1) ES2345552T3 (en)
PT (1) PT1613340E (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2826875A1 (en) * 2011-02-09 2012-08-16 Sciclone Pharmaceuticals, Inc. Thymosin alpha peptide for preventing, reducing the severity of, and treating infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (en) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
CN100342907C (en) 2007-10-17
ES2345552T3 (en) 2010-09-27
PT1613340E (en) 2010-08-19
DE602004027127D1 (en) 2010-06-24
CN1767847A (en) 2006-05-03

Similar Documents

Publication Publication Date Title
CY1122178T1 (en) POLYPEPTIDES
ECSP105739A (en) NEUTRALIZATION ANTIBODIES AGAINST GDF-8
CY1116635T1 (en) METHOD FOR FILING FOLLOWING AN ACTIVE FACTOR
CY1111526T1 (en) HSV NS5B CYCLOPROPYL SUSPENDED INHIBITIONS
CY1119753T1 (en) LYSINIC ALPHA AZERTONAMI
BRPI0513370A (en) use of a combination of pegylated cyclosporine and interferon for treatment of hepatitis c (hcv)
FI20050814A0 (en) Procedure for observing autoantibodies formed in rheumatoid arthritis
HUP0400719A2 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
ATE495739T1 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING LEVODOPA AND CARBIDOPA
MA30978B1 (en) HYALURONIC ACID GEL FOR INTRADERMAL INJECTION
CY1113736T1 (en) Uteroaryl-urine and their use as glucokinase activators
UY28258A1 (en) THERAPEUTIC TREATMENT
CY1111613T1 (en) METHODS FOR TREATMENT OF HIV INFECTION
BR0214029A (en) Methods and compositions for using stromal cells to support embryonic and adult stem cells
MXPA06003474A (en) Melanocortin receptor agonists.
NO20054912D0 (en) Treatment of aspergillus infections with thymosin alpha 1
EA200100362A1 (en) METHODS OF TREATMENT OF MULTIPLE MYELOMA AND INDUCED MYELOUS BONE RESORPTION BY MEANS OF ANTAGONISTS INTEGRINES
ATE258029T1 (en) STERILIZATION AND LIVING CLIPS
CY1113277T1 (en) USE OF THYMOSYNUM α1, SINGLE OR IN COMBINATION WITH RTX3 OR GANSICLOVIR, FOR KYTOMEGALIUM INFECTION TREATMENT
CY1110218T1 (en) Treatment of Aspergillus infections with thymic alpha 1
BR0312554A (en) Surgical apparatus for the removal of tissue cells from a biological structure
DE60107560D1 (en) PRE-IPOCYTE-CONTAINING BIOMATERIALS FOR REGENERATING SOFT TISSUE
ATE410448T1 (en) NEW PEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS PEPTIDE
DE602004003364D1 (en) DEVICE FOR BEAUTY CARE OF LIMBS
DE60029327D1 (en) NUCLEIC ACID AND AMINO-ACID SEQUENCES OF INFECTIOUS SALMON ANAEMIA VIRUS, AND THEIR USE AS VACCINES